Please login to the form below
Abivax
This page shows the latest Abivax news and features for those working in and with pharma, biotech and healthcare.
Trial data suggest Abivax’ drug may clear latent HIV
The drug reduced HIV DNA in cells over 28 days. French biotech Abivax has new data for its HIV drug candidate ABX464 that suggest it may suppress latent HIV in reservoirs – ... Those anti-inflammatory properties have encouraged Abivax to carry out a
Latest news
-
J&J buys firm seeking hepatitis B cure
therapeutic vaccine developer Abivax are trying to change.
More from news
Approximately 1 fully matching, plus 1 partially matching documents found.
Latest Intelligence
-
The race for a HIV ‘cure’
Another company working on a similar candidate is French biotech Abivax.
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Featured jobs
- Senior Medical Writer, MedComms Agency
-
Salary TBC
- Account Manager– Medical Communications
-
(Negotiable - depending on experience)
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
-
Principal Medical Writer
-
£48 - 58, 000 according to skills and experience benefits
- Account Director or Senior Account Director
-
Salary TBC
-
Vice President
-
Competitive Salary Offered
- Director of Scientific Services, Medical Communications, Six fig...
-
Six figure salary
-
Consultant
-
competitive salary
Subscribe to our email news alerts
- Moving annual total (MAT)
- Novartis links up with NHS for speedy access to cholesterol drug inclisiran
- Novo Nordisk gets MACE prevention claim for Ozempic in US
- Clovis leapfrogs PARP rivals, filing Rubraca for prostate cancer
- Lilly will aim for one $1bn-$5bn deal per quarter in 2020
- PMEA 2019 Photo Gallery - PMEA
- FDA fast-tracks GSK’s anti-BCMA drug for multiple myeloma
- EU group calls for 'targeted actions' to mitigate impact of Brexit
- FDA approves Horizon's thyroid eye disease drug ahead of schedule
- White Paper for download - Explaining the price of your product
- Presidential hopeful Bernie Sanders criticises BioMarin’s gene therapy price
- AZ’s Imfinzi scores orphan drug status in liver cancer
PMHub
Hanson Zandi
Hanson Zandi is a Creative and Digital Healthcare Agency. We combine 30 years’ experience with the enthusiasm of a start-up...
Latest intelligence
- White Paper for download - Explaining the price of your product
- In this white paper, he breaks down the pricing options available to you, shares stories from his extensive experiences, and talks you through how to better define your pricing, step-by-step....
- OPEN Health expands offering with the launch of a new Learning & Development specialist team
- Enhanced expertise to deliver impactful internal training programmes for healthcare clients...
- The changing nature of approvals – what does the future hold?
- The 2019 CMR International Pharmaceutical R&D Factbook...
Quick links
Infographics
